Current Research

Research for AdCC is ongoing. The following advances may still be under investigation in clinical trials and may not be approved or available at this current time. Always discuss all diagnostic and treatment options with your doctor.

Antiangiogenesis research. Antiangiogenesis research, which explores how a tumor develops its blood supply and how agents disrupt these blood supplies that feed the tumor, may benefit people with AdCC.

Targeted therapies. New drugs called targeted therapies are designed to stop the growth of cancer cells at the level of genes and proteins. Currently, targeted therapies for cancer are being developed, and some of them may be useful in the treatment of AdCC.

Newer chemotherapy. Several clinical trials are examining the effects of relatively new chemotherapy alone, or in combination with other drugs, in the control of metastatic or locally recurrent AdCC.